{"title":"飞秒激光辅助层内角膜环段植入联合角膜胶原交联治疗透明性圆锥角膜","authors":"M. Abozaid","doi":"10.4103/ejos.ejos_48_20","DOIUrl":null,"url":null,"abstract":"Purpose To evaluate the safety and efficacy of combined femtosecond laser-assisted intrastromal corneal ring segments implantation plus accelerated transepithelial corneal collagen cross-linking (ATE-CXL) in cases of pellucid-like keratoconus (PLK). Patients and methods This retrospective study included 25 eyes of 13 patients with PLK. Cases were divided into two groups: group 1 consisted of 13 eyes (seven patients) that had been treated by femtosecond laser-assisted Kerarings implantation and ATE-CXL in the same session, whereas group 2 included 12 eyes (six patients) that had been treated with ATE-CXL alone. Results After 1 year of surgery, the mean uncorrected visual acuity (UCVA) of group 1 improved from 0.94±23 (logMAR) to 0.73±18, whereas the mean best-corrected visual acuity improved from 0.75±16 to 0.49±0.22. The mean preoperative maximum keratometry (Kmax) was 65.23±5.03 D, whereas the mean postoperative Kmax was 53.92±4.21 D. However, in group 2, the preoperative mean UCVA was 0.63±0.31 and the postoperative UCVA was 0.55±0.29, whereas the mean best-corrected visual acuity changed from 0.31±0.26 to 0.23±0.19. The mean preoperative Kmax was 51.38±3.73 D, whereas the mean postoperative Kmax was 48.43±2.98 D. Conclusion Combined femtosecond laser-assisted Kerarings implantation and ATE-CXL is safe and effective in the treatment of PLK.","PeriodicalId":31572,"journal":{"name":"Journal of the Egyptian Ophthalmological Society","volume":"113 1","pages":"147 - 152"},"PeriodicalIF":0.1000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combined femtosecond laser-assisted intrastromal corneal ring segments implantation and corneal collagen cross-linking for treatment of pellucid-like keratoconus\",\"authors\":\"M. Abozaid\",\"doi\":\"10.4103/ejos.ejos_48_20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose To evaluate the safety and efficacy of combined femtosecond laser-assisted intrastromal corneal ring segments implantation plus accelerated transepithelial corneal collagen cross-linking (ATE-CXL) in cases of pellucid-like keratoconus (PLK). Patients and methods This retrospective study included 25 eyes of 13 patients with PLK. Cases were divided into two groups: group 1 consisted of 13 eyes (seven patients) that had been treated by femtosecond laser-assisted Kerarings implantation and ATE-CXL in the same session, whereas group 2 included 12 eyes (six patients) that had been treated with ATE-CXL alone. Results After 1 year of surgery, the mean uncorrected visual acuity (UCVA) of group 1 improved from 0.94±23 (logMAR) to 0.73±18, whereas the mean best-corrected visual acuity improved from 0.75±16 to 0.49±0.22. The mean preoperative maximum keratometry (Kmax) was 65.23±5.03 D, whereas the mean postoperative Kmax was 53.92±4.21 D. However, in group 2, the preoperative mean UCVA was 0.63±0.31 and the postoperative UCVA was 0.55±0.29, whereas the mean best-corrected visual acuity changed from 0.31±0.26 to 0.23±0.19. The mean preoperative Kmax was 51.38±3.73 D, whereas the mean postoperative Kmax was 48.43±2.98 D. Conclusion Combined femtosecond laser-assisted Kerarings implantation and ATE-CXL is safe and effective in the treatment of PLK.\",\"PeriodicalId\":31572,\"journal\":{\"name\":\"Journal of the Egyptian Ophthalmological Society\",\"volume\":\"113 1\",\"pages\":\"147 - 152\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2020-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Egyptian Ophthalmological Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ejos.ejos_48_20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian Ophthalmological Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ejos.ejos_48_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Combined femtosecond laser-assisted intrastromal corneal ring segments implantation and corneal collagen cross-linking for treatment of pellucid-like keratoconus
Purpose To evaluate the safety and efficacy of combined femtosecond laser-assisted intrastromal corneal ring segments implantation plus accelerated transepithelial corneal collagen cross-linking (ATE-CXL) in cases of pellucid-like keratoconus (PLK). Patients and methods This retrospective study included 25 eyes of 13 patients with PLK. Cases were divided into two groups: group 1 consisted of 13 eyes (seven patients) that had been treated by femtosecond laser-assisted Kerarings implantation and ATE-CXL in the same session, whereas group 2 included 12 eyes (six patients) that had been treated with ATE-CXL alone. Results After 1 year of surgery, the mean uncorrected visual acuity (UCVA) of group 1 improved from 0.94±23 (logMAR) to 0.73±18, whereas the mean best-corrected visual acuity improved from 0.75±16 to 0.49±0.22. The mean preoperative maximum keratometry (Kmax) was 65.23±5.03 D, whereas the mean postoperative Kmax was 53.92±4.21 D. However, in group 2, the preoperative mean UCVA was 0.63±0.31 and the postoperative UCVA was 0.55±0.29, whereas the mean best-corrected visual acuity changed from 0.31±0.26 to 0.23±0.19. The mean preoperative Kmax was 51.38±3.73 D, whereas the mean postoperative Kmax was 48.43±2.98 D. Conclusion Combined femtosecond laser-assisted Kerarings implantation and ATE-CXL is safe and effective in the treatment of PLK.